OTC : YPHDF
$0 (0.0%)
OTC
Simon Michel
Medical - Specialties
Healthcare
YPHDF
2025
CH
USD
0.35
1.07
0.87
0.10
0.14
$730.98M
6.93
6.97
452.81
0.83
$16.3
$221.93M
30.36%
32.97%
28.54%
16.48%
23.62
0.24
0.24
3/5
3 Analysts
%
7.60
8/9
$20.62M
$1.35B
$598.46M
$331.7M
$5.3B
7.25
15.51
1.07
28.54%
14.23%
4.25%
0.22%
$142.71
113 days
| Name | Title |
|---|---|
| Nicolas Meyer | Chief Legal Officer & Secretary and Member of Executive Board |
| Frank Mengis | COO, Deputy CEO Member of Executive Board |
| Michael Zaugg | Chief Corporate Officer & Member of Executive Board |
| Samuel Kunzli | Chief Financial Officer & Member of Executive Board |
| Simon Michel | CEO, Member of Executive Board & Member of the Board |
| Ulrike Bauer | Chief Business Officer & Member of Executive Board |
| Sam Ghezelbash | Head of Investor Relations & M&A |
No votes yet today — be the first to share your view!
About Ypsomed Holding AG (OTC:YPHDF) Stock
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manu ... facturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Ypsomed Holding AG (YPHDF) Q4 2026 Earnings Call Transcript
2026-05-20 16:10:53
Ypsomed Holding AG (YPHDF) Q4 2026 Earnings Call Transcript
Frequently Asked Questions
What is the current Ypsomed Holding AG (YPHDF) stock price?
Ypsomed Holding AG(OTC:YPHDF) stock price is $484.96 in the last trading session. During the trading session, YPHDF stock reached the peak price of $535.75 while $354.924 was the lowest point it dropped to. The percentage change in YPHDF stock occurred in the recent session was 0.0% while the dollar amount for the price change in YPHDF stock was $0.
YPHDF's industry and sector of operation?
The OTC listed YPHDF is part of Medical - Specialties industry that operates in the broader Healthcare sector.
Who are the executives of YPHDF?
Nicolas Meyer
| Chief Legal Officer & Secretary and Member of Executive Board
Frank Mengis
| COO, Deputy CEO Member of Executive Board
Michael Zaugg
| Chief Corporate Officer & Member of Executive Board
Samuel Kunzli
| Chief Financial Officer & Member of Executive Board
Simon Michel
| CEO, Member of Executive Board & Member of the Board
How many employees does YPHDF have?
Number of YPHDF employees currently stands at 2025. YPHDF operates from Brunnmattstrasse 6, Burgdorf, BE 3401, CH.
Link for YPHDF official website?
Official Website of YPHDF is: https://www.ypsomed.com
How do I contact YPHDF?
YPHDF could be contacted at phone #41 34 424 41 11 and can also be accessed through its website. YPHDF operates from Brunnmattstrasse 6, Burgdorf, BE 3401, CH.
How many shares of YPHDF are traded daily?
The average number of YPHDF shares traded daily for last 3 months was 2.
What is the market cap of YPHDF currently?
The market value of YPHDF currently stands at $6.38B with its latest stock price at $484.96